July 10, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Christian S. Hinrichs from Rutgers Cancer Institute of New Jersey.
Rutgers Cancer Institute of New Jersey (CINJ) is a cancer treatment and research institution that is a part of Rutgers University and is located in New Brunswick, New Jersey. CINJ is one of only 51 Comprehensive Cancer Centers in the nation designated by the National Cancer Institute and the only one in New Jersey located in the heart of New Brunswick.
Dr. Christian S. Hinrichs joins Rutgers Cancer Institute as Chief of the Section of Cancer Immunotherapy and Co-Director of the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence following his tenure at the National Institutes of Health (NIH). Dr. Hinrichs is a tenured Professor of Medicine at the Rutgers Robert Wood Johnson Medical School, and holds the position of Program Co-leader of the Cancer Metabolism and Growth Program. Dr. Hinrichs conducts basic research and clinical research to develop T-cell therapies for HPV-associated cancers and other epithelial malignancies.
Through the collaboration and our mutual efforts, we are dedicated to building a series of more personalized cancer therapeutic methods targeting a broad spectrum of human cancers.